A detailed history of Samsara Bio Capital, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 78,131 shares of KRON stock, worth $74,224. This represents 0.05% of its overall portfolio holdings.

Number of Shares
78,131
Previous 78,131 -0.0%
Holding current value
$74,224
Previous $96,000 18.75%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.34 - $2.62 $104,695 - $204,703
78,131 New
78,131 $114,000
Q2 2021

Aug 17, 2021

SELL
$20.08 - $29.02 $1.77 Million - $2.56 Million
-88,119 Reduced 53.0%
78,131 $1.87 Million
Q4 2020

Feb 17, 2021

BUY
$26.68 - $38.23 $4.44 Million - $6.36 Million
166,250 New
166,250 $4.97 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.9M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.